Balyasny Asset Management
BLUE

Balyasny Asset Management’s bluebird bio BLUE Stock Holding History

Balyasny Asset Management’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-11,350
Closed -$223K – 2752
2024
Q2 		$223K Buy
+11,350
New +$227K ﹤0.01% 2309
2024
Q1 		– Sell
-1,707
Closed -$47.1K – 2629
2023
Q4 		$47.1K Buy
+1,707
New +$104K ﹤0.01% 2409
2023
Q2 		– Sell
-72,512
Closed -$4.61M – 2297
2023
Q1 		$4.61M Buy
72,512
+25,132
+53% +$2.87M 0.01% 1116
2022
Q4 		$6.56M Buy
47,380
+41,463
+701% +$5.84M 0.02% 914
2022
Q3 		$749K Buy
5,917
+1,366
+30% +$155K ﹤0.01% 1913
2022
Q2 		$377K Buy
+4,551
New +$353K ﹤0.01% 2058
2021
Q1 		– Sell
-2,231
Closed -$1.25M – 1767
2020
Q4 		$1.25M Sell
2,231
-4,872
-69% -$3.09M 0.01% 977
2020
Q3 		$4.96M Buy
+7,103
New +$5.54M 0.04% 614
2019
Q3 		– Sell
-1,382
Closed -$2.28M – 1185
2019
Q2 		$2.28M Sell
1,382
-3,616
-72% -$6.26M 0.01% 841
2019
Q1 		$10.2M Sell
4,998
-505
-9% -$889K 0.07% 378
2018
Q4 		$7.07M Sell
5,503
-12,700
-70% -$19.5M 0.05% 432
2018
Q3 		$34.4M Sell
18,203
-2,023
-10% -$4.18M 0.16% 181
2018
Q2 		$41.1M Buy
20,226
+3,625
+22% +$8.26M 0.19% 136
2018
Q1 		$36.7M Buy
16,601
+1,120
+7% +$2.85M 0.15% 190
2017
Q4 		$35.7M Sell
15,481
-23,360
-60% -$47.4M 0.11% 239
2017
Q3 		$69.1M Buy
38,841
+8,796
+29% +$12.3M 0.27% 89
2017
Q2 		$40.9M Sell
30,045
-15,532
-34% -$18.7M 0.17% 159
2017
Q1 		$53.7M Sell
45,577
-8,929
-16% -$9.11M 0.25% 99
2016
Q4 		$43.6M Buy
54,506
+12,148
+29% +$9.65M 0.23% 115
2016
Q3 		$37.2M Buy
42,358
+24,975
+144% +$18.1M 0.22% 148
2016
Q2 		$9.75M Buy
17,383
+734
+4% +$416K 0.06% 356
2016
Q1 		$9.17M Buy
16,649
+6,284
+61% +$3.86M 0.05% 419
2015
Q4 		$8.62M Buy
10,365
+10,004
+2,771% +$9.99M 0.06% 394
2015
Q3 		$400K Buy
+361
New +$658K ﹤0.01% 850

Other funds holding BLUE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Balyasny Asset Management's BLUE Position: Q3 2024 in Review

Balyasny Asset Management sold out of bluebird bio (BLUE) in Q3 2024, closing a stake of 11,350 shares — an estimated $223K sold.

Balyasny Asset Management first reported a position in BLUE in Q3 2015 and held it in 24 quarters. The position peaked at $69.1M in Q3 2017. 140 funds tracked by Wall St. Rank hold BLUE as of Q3 2024.

  • Balyasny Asset Management reported no remaining bluebird bio position as of Q3 2024 after selling out during the quarter.
  • Balyasny Asset Management sold 11,350 bluebird bio shares in Q3 2024, an estimated $223K.
  • Balyasny Asset Management first reported a position in bluebird bio in Q3 2015 and held it in 24 quarters.
  • Balyasny Asset Management's bluebird bio position peaked at $69.1M in Q3 2017.
  • 140 funds tracked by Wall St. Rank held bluebird bio as of Q3 2024.

Based on Balyasny Asset Management's 13F filing for Q3 2024, filed 14 Nov 2024.